CN1686424A - 一种含有黄芩和柴胡的药物组合物及其制备方法 - Google Patents
一种含有黄芩和柴胡的药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN1686424A CN1686424A CNA2005100678557A CN200510067855A CN1686424A CN 1686424 A CN1686424 A CN 1686424A CN A2005100678557 A CNA2005100678557 A CN A2005100678557A CN 200510067855 A CN200510067855 A CN 200510067855A CN 1686424 A CN1686424 A CN 1686424A
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- radix bupleuri
- ethanol
- radix scutellariae
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims description 27
- 239000000203 mixture Substances 0.000 title claims description 24
- 241000202726 Bupleurum Species 0.000 title abstract description 5
- 241000207929 Scutellaria Species 0.000 title abstract 2
- 239000000284 extract Substances 0.000 claims abstract description 55
- 239000003814 drug Substances 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 93
- 239000008194 pharmaceutical composition Substances 0.000 claims description 36
- 239000007788 liquid Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 15
- 238000001035 drying Methods 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 13
- 229920002472 Starch Polymers 0.000 claims description 10
- 238000002347 injection Methods 0.000 claims description 10
- 239000007924 injection Substances 0.000 claims description 10
- 239000008107 starch Substances 0.000 claims description 10
- 235000019698 starch Nutrition 0.000 claims description 10
- 239000003937 drug carrier Substances 0.000 claims description 9
- 238000002481 ethanol extraction Methods 0.000 claims description 9
- 238000002386 leaching Methods 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 229940023488 pill Drugs 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 3
- 238000003916 acid precipitation Methods 0.000 claims description 2
- 239000007910 chewable tablet Substances 0.000 claims description 2
- 229940068682 chewable tablet Drugs 0.000 claims description 2
- 239000007919 dispersible tablet Substances 0.000 claims description 2
- 239000007938 effervescent tablet Substances 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000007909 solid dosage form Substances 0.000 claims 1
- 206010022000 influenza Diseases 0.000 abstract description 12
- 206010004542 Bezoar Diseases 0.000 abstract 1
- 206010057190 Respiratory tract infections Diseases 0.000 abstract 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 12
- 230000001276 controlling effect Effects 0.000 description 11
- 238000010438 heat treatment Methods 0.000 description 10
- 241000700605 Viruses Species 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 230000036760 body temperature Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 4
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 4
- 229960003321 baicalin Drugs 0.000 description 4
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 4
- 238000011026 diafiltration Methods 0.000 description 4
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 240000004534 Scutellaria baicalensis Species 0.000 description 3
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229940071462 oralone Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- -1 preferably Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
中心0102030405合计 | 入组病例数 | 脱落病例数 | 剔除病例数 | 完成病例数 | ||||||||||||
A组 | B组 | C组 | 合计 | A组 | B组 | C组 | 合计 | A组 | B组 | C组 | 合计 | A组 | B组 | C组 | 合计 | |
2424242424120 | 2424242424120 | 2424242424120 | 7272727272360 | 030003 | 150028 | 140027 | 21200418 | 100001 | 200002 | 000000 | 300003 | 2321242424116 | 2119242422110 | 2320242422113 | 6760727268339 |
中心 | 符合方案集 | 意向性分析集 | 安全集 | |||||||||
A组 | B组 | C组 | 合计 | A组 | B组 | C组 | 合计 | A组 | B组 | C组 | 合计 | |
0102030405 | 2321242424 | 2149242422 | 2320242422 | 6760727268 | 2322242424 | 2221242422 | 2320242422 | 6863727268 | 2424242424 | 2424242424 | 2424242424 | 7272727272 |
合计 | 116 | 110 | 113 | 339 | 117 | 113 | 113 | 343 | 120 | 120 | 120 | 360 |
组别 | n | 痊愈 | 显效 | 有效 | 无效 | 总显效率 | 总有效率 | ||||
n | % | n | % | n | % | n | % | ||||
A组B组C组 | 116110113 | 504629 | 43.1041.8225.66 | 505053 | 43.1045.4546.90 | 131130 | 11.2110.0026.55 | 331 | 2.592.730.88 | 86.2087.2772.59 | 97.4197.2799.12 |
组别 | n | 痊愈 | 显效 | 有效 | 无效 | 总显效率 | 总有效率 | ||||
N | % | n | % | n | % | n | % | ||||
A组B组C组 | 116110113 | 504829 | 46.5543.6425.66 | 504653 | 43.1041.8246.90 | 91330 | 7.7611.0026.55 | 331 | 2.592.730.88 | 89.6585.4672.59 | 97.4197.2799.12 |
组别 | n | 治疗前x±S | 治疗后x±S | 差值x±S | F | P |
A组B组C组 | 116110113 | 37.85±0.4137.88±0.3837.95±0.43 | 36.82±0.4236.84±0.3536.89±0.48 | 1.031±0.4321.050±0.4241.028±0.398 | 0.09 | 0.915 |
症状发热微恶寒咽痛 | 组别A组B组C组A组B组C组 | n116110113116110113 | 治前 | 治中 | 治后 | |||||||||
无000000 | 轻483642695459 | 中525749374144 | 重161722101510 | 无695861182117 | 轻384338917280 | 中991371714 | 重001002 | 无10810193817359 | 轻5518343749 | 中341104 | 重001001 |
组别 | n | 治前 | 治后 | 组内 | 组间 | |||
正常 | 红 | 正常 | 红 | P* | X2 | P | ||
A组B组C组 | 116110113 | 444 | 112106109 | 827666 | 343447 | 0.000.000.00 | 4.512 | 0.105 |
组别 | n | 治前 | 治后 | 组内P* | 组间 | |||||
正常 | 簿黄 | 其他 | 正常 | 簿黄 | 其他 | X2 | P | |||
A组B组C组 | 116110113 | 788 | 109102105 | 000 | 807775 | 363338 | 000 | 0.000.000.00 | 0.362 | 0.834 |
组别 | n | 治前 | 治后 | 组内 | 组间P* | |||
正常 | 浮数 | 正常 | 浮数 | X2 | P | |||
A组B组C组 | 116110113 | 343632 | 827481 | 11110595 | 5518 | 71.34 | 0.000.000.00 | 0.003 |
组别 | n | 治前 | 治后 | 组内 | 组间 | ||||
阴性(%) | 阳性(%) | 阴性(%) | 阳性(%) | Z | P | X2 | P | ||
A组B组C组 | 938994 | 65(69.89)59(66.29)64(68.82) | 28(30.11)30(23.71)29(68.82) | 89(95.70)86(96.63)86(31.18) | 4(4.30)3(3.37)8(7.53) | 4.8995.1964.690 | 0.000.000.00 | 1.807 | 0.405 |
组别 | n | ~12 | ~24 | ~48 | ~72 | 未起效 | X2 | P |
A组B组C组 | 116110113 | 838677 | 161318 | 9610 | 111 | 777 | 1.445 | 0.695 |
组别 | n | x±S | F | P |
A组B组C组 | 109105107 | 10.29±11.809.67±8.8011.73±13.32 | 0.90 | 0.41 |
组别 | n | ~12 | ~24 | ~48 | ~72 | 未起效 | X2 | P |
A组B组C组 | 116110113 | 533744 | 202019 | 152216 | 7148 | 211726 | 9.32 | 0.32 |
组别 | n | x±S | F | P |
A组B组C组 | 1069590 | 25.59±27.9226.17±21.9821.97±20.72 | 0.84 | 0.43 |
Claims (18)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100678557A CN1686424B (zh) | 2005-04-28 | 2005-04-28 | 一种含有黄芩和柴胡的药物组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100678557A CN1686424B (zh) | 2005-04-28 | 2005-04-28 | 一种含有黄芩和柴胡的药物组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1686424A true CN1686424A (zh) | 2005-10-26 |
CN1686424B CN1686424B (zh) | 2010-04-21 |
Family
ID=35304466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005100678557A Active CN1686424B (zh) | 2005-04-28 | 2005-04-28 | 一种含有黄芩和柴胡的药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1686424B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100420456C (zh) * | 2006-03-14 | 2008-09-24 | 北京国丹药物技术开发有限公司 | 复方柴胡灌肠液制剂及其制备方法 |
CN102670818A (zh) * | 2012-04-24 | 2012-09-19 | 吉林大学珠海学院 | 一种镇痛消炎的复方黄芩制剂及其制备方法 |
CN106924448A (zh) * | 2017-01-10 | 2017-07-07 | 湖南华纳大药厂天然药物有限公司 | 治疗风热感冒的药物组合物及其制备方法 |
CN110585269A (zh) * | 2019-10-11 | 2019-12-20 | 吉林农业科技学院 | 复方柴胡黄芩栓的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR890016973A (ko) * | 1988-05-16 | 1989-12-14 | 김영설 | 우황청심액 및 그 제조방법 |
-
2005
- 2005-04-28 CN CN2005100678557A patent/CN1686424B/zh active Active
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100420456C (zh) * | 2006-03-14 | 2008-09-24 | 北京国丹药物技术开发有限公司 | 复方柴胡灌肠液制剂及其制备方法 |
CN102670818A (zh) * | 2012-04-24 | 2012-09-19 | 吉林大学珠海学院 | 一种镇痛消炎的复方黄芩制剂及其制备方法 |
CN106924448A (zh) * | 2017-01-10 | 2017-07-07 | 湖南华纳大药厂天然药物有限公司 | 治疗风热感冒的药物组合物及其制备方法 |
CN106924448B (zh) * | 2017-01-10 | 2020-04-24 | 湖南华纳大药厂天然药物有限公司 | 治疗风热感冒的药物组合物及其制备方法 |
CN110585269A (zh) * | 2019-10-11 | 2019-12-20 | 吉林农业科技学院 | 复方柴胡黄芩栓的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1686424B (zh) | 2010-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1836720A (zh) | 一种治疗关节炎或痛风的中药组合物及其制备方法 | |
CN101032547A (zh) | 一种抗炎抗病毒的药物组合物 | |
CN100512796C (zh) | 一种含有黄芩苷和柴胡的药物组合物及其制备方法 | |
CN1425447A (zh) | 一种治疗小儿食积咳嗽的中药组合物及其制备方法 | |
CN1686424B (zh) | 一种含有黄芩和柴胡的药物组合物及其制备方法 | |
CN110623998B (zh) | 一种用于糖尿病周围神经病变的中药组合物及其应用 | |
CN102228547B (zh) | 一种中药组合物在制备治疗胰腺炎和/或胆囊炎药物中的应用 | |
CN104940781A (zh) | 一种用于治疗白脉病的藏药组合物及其制备方法 | |
CN1823982A (zh) | 舒肝健脾的中药制剂及其制备方法 | |
CN103520684B (zh) | 一种降血糖的中药复合物 | |
CN103169825A (zh) | 一种用于治疗畜禽肠道疾病的药物 | |
CN101804135A (zh) | 治疗禽球虫病的复方组合药物及其制备方法 | |
CN1237998C (zh) | 治疗小儿咳喘的泡腾片 | |
CN104352672A (zh) | 一种含龟板的治疗糖尿病的中药组合物 | |
CN103536879A (zh) | 一种治疗糖尿病的药物组合物以及制备方法 | |
CN1526441A (zh) | 藿香正气胶囊及其制备方法与应用 | |
CN108553584B (zh) | 一种辅助降血糖的组合物及其应用 | |
CN110448622B (zh) | 治疗热性感冒的药物及其制备方法和应用 | |
CN108704080B (zh) | 一种治疗肾阴虚型抑郁症的药物及其制备方法 | |
CN1150918C (zh) | 珠子参有效成份制剂及制备方法 | |
CN106377651A (zh) | 一种从土茯苓中提取防治高尿酸血症及痛风药用单体的制备方法 | |
CN101391076A (zh) | 一种治疗糖尿病的灰蔸巴提取物中药复合制剂 | |
CN1569085A (zh) | 一种治疗风湿类风湿性关节炎的药物组合物 | |
CN105535070A (zh) | 治疗糖尿病的药物组合物及其制备方法和应用 | |
CN1957959A (zh) | 治疗慢性咽炎、抗过敏的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Hainan Wanzhou Green Pharmaceutical Co., Ltd. Assignor: Kuang Jixian Contract record no.: 2011990000648 Denomination of invention: Medicinal composition containing scutellaria and bupleurum and its preparation method Granted publication date: 20100421 License type: Exclusive License Open date: 20051026 Record date: 20110715 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190201 Address after: 225300 No. 9, Longfeng Tang Road, Yongan Town, Taizhou, Jiangsu. Co-patentee after: Yangtze River Pharmaceutical Co., Ltd. Patentee after: Yangzi Pharmaceutical Group Jiangsu Longfeng traditional Chinese Medicine Co., Ltd. Address before: Room 1101, Unit C3-1, Wanlilong Garden, 85 Jinlong Road, Haikou City, Hainan Province Patentee before: Kuang Jixian |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Kuang Jixian Document name: Notification of Passing Examination on Formalities |